Action ISLE.U ISLEWORTH HEALTHCARE ACQUISITION CORP.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription
Instrument Inactif

Communiqués Isleworth Healthcare Acquisition Corp. Nasdaq

Actions

ISLE.U

US46468P2011

Communiqués

Recherche
Voir les résultats
Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !
Inscription 100% Gratuite
ISLEWORTH HEALTHCARE ACQUISITION CORP. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
Isleworth Healthcare Acquisition Corp. Announces Cancellation of Special Meeting of Shareholders, Redemption of Public Shares and Subsequent Dissolution
PR
ISLEWORTH HEALTHCARE ACQUISITION CORP. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
AQ
ISLEWORTH AND CYTOVIA TERMINATE MERGER AGREEMENT
PR
Isleworth Healthcare Acquisition : AND CYTOVIA TERMINATE MERGER AGREEMENT - Form 8-K
PU
ISLEWORTH HEALTHCARE ACQUISITION CORP. : Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Other Events, Financial Statements and Exhibits (form 8-K)
AQ
ISLEWORTH HEALTHCARE ACQUISITION CORP. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
ISLEWORTH HEALTHCARE ACQUISITION CORP. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)
AQ
Cytovia Therapeutics presents antitumor activity of its CD38-Targeting Flex-NK™ Cell Engager antibody at EHA 2022 Congress
PR
Isleworth Healthcare Acquisition : Cytovia Therapeutics Appoints Luca Scavo as Chief Financial Officer and James Priour as Chief Product Officer - Form 8-K
PU
ISLEWORTH HEALTHCARE ACQUISITION CORP. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
Isleworth Healthcare Acquisition : Quarterly Report (Form 10-Q)
PU
ISLEWORTH HEALTHCARE ACQUISITION CORP. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
AQ
Cytovia Therapeutics to Present In Vivo Multiple Myeloma Data of its CD38-Targeting Flex-NK™ Cell Engager at EHA 2022 Congress
PR
ISLEWORTH HEALTHCARE ACQUISITION CORP. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
Cytovia Therapeutics to Present at AACR Special Conference on Advances in the Pathogenesis and Molecular Therapies of Liver Cancer
PR
Isleworth Healthcare Acquisition : and Cytovia Therapeutics Announce Agreement for Business Combination to Create Publicly Listed Company Focused on Empowering Natural Killer Cell Therapeutics to Fight Cancer - Form 8-K
PU
ISLEWORTH HEALTHCARE ACQUISITION CORP. : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
ISLEWORTH HEALTHCARE ACQUISITION CORP. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)
AQ
Isleworth Healthcare Acquisition : Current Report (Form 8-K)
PU
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action ISLE
  4. Action ISLE.U
  5. Actualités Isleworth Healthcare Acquisition Corp.
  6. Communiqués